skip to Main Content

Debate Continues on Optimal Neoadjuvant Regimen in Resectable Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Radiation therapy is not an essential component of neoadjuvant therapy for patients with resectable pancreatic cancer, according to Michael A. Choti, MD, MBA, FACS, who added that chemotherapy is the main treatment that should be used.

“For patients with operable cancer, the standard in the past was to operate and remove the tumor or to perform surgery and then administer adjuvant therapy after the procedure,” said Choti. “However, it is becoming clear that neoadjuvant therapy is where we are headed in the management of potentially operable pancreatic cancer.” Read more . . . 

Back To Top